latentbrief
Back to news
General1h ago

Pharma Companies Partner with AI Firms

BioSpace1 min brief

In brief

  • Eli Lilly and Bristol Myers Squibb have partnered with AI companies to improve drug development.
  • Bristol Myers Squibb will use Anthropic's Claude model to streamline workflows and improve data analysis.
  • Lilly will integrate its AI engine into Collaborative Drug Discovery's database to share research data with other companies.
    • This will give biotechs access to decades of Lilly's research data to train their models.
  • New partnerships will help the biopharma industry use artificial intelligence to develop new drugs faster.
  • The industry will continue to change with more AI deals in the future.

Terms in this brief

Claude
Claude is a large language model developed by Anthropic, known for its ability to perform complex reasoning and generate human-like text. It's used in various applications, including drug development, where it helps streamline workflows and analyze data.
Collaborative Drug Discovery
Collaborative Drug Discovery refers to a platform or initiative that allows multiple companies and researchers to share and collaborate on drug discovery data. In this case, Eli Lilly is integrating its AI engine into this database to share decades of research with other biotech companies, enabling them to train their models more effectively.

Read full story at BioSpace

More briefs